Walleye Capital’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Walleye Capital's TEVA Position: Q3 2026 in Review
Walleye Capital opened a new position in Teva Pharmaceutical Industries (TEVA) in Q3 2026: 159,834 shares worth $6.33M. The stake represents 0.01% of the portfolio and ranks #1669 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TEVA as recently as Q1 2026.
Walleye Capital first reported a position in TEVA in Q1 2019 and has held it in 14 quarters since. The position peaked at $22.2M in Q4 2024. 595 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Walleye Capital held 159,834 shares of Teva Pharmaceutical Industries worth $6.33M as of Q3 2026.
- Teva Pharmaceutical Industries was a new Walleye Capital position in Q3 2026.
- Teva Pharmaceutical Industries made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1669 holding.
- Walleye Capital first reported a position in Teva Pharmaceutical Industries in Q1 2019 and has held it in 14 quarters since.
- Walleye Capital's Teva Pharmaceutical Industries position peaked at $22.2M in Q4 2024.
- 595 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.